newsfilter
← Latest News
GlobeNewswire·

Prenetics’ IM8 Names Brian J. Rosin as Successor Chief Financial Officer

PRE
  • Brian J. Rosin will succeed Stephen Lo as Chief Financial Officer of Prenetics Global Limited effective December 31, 2026, with the Board expected to formalize the appointment on November 12, 2026.
  • Rosin, currently CFO of IM8, will serve as CFO-designate through year-end while continuing to lead IM8 finance before taking over the global finance organization.
  • The transition completes a planned leadership shift as IM8 now represents almost all of Prenetics' revenue, eliminating the need for a separate IM8 CFO role.
  • Prenetics' finance leadership function is now based in the United States, reinforced by the addition of U.S.-based Vice President Financial Controller Cindy Tat in August 2026.
  • Stephen Lo will serve as CFO until December 30, 2026, to ensure an orderly transition, after which he will remain with the Company as a Senior Advisor.
  • Prenetics will report third quarter 2026 financial results on November 18, 2026, 2026, 2026, with a live-streamed earnings event on Stocktwits at 8:30 a.m. Eastern Time.
  • The live stream will be accessible at https://stocktwits.com/symbol/PRE, with investor questions accepted via email at investors@prenetics.com.
  • CEO Danny Yeung stated the U.S.-based structure aligns finance operations with IM8's largest market primary capital market.
  • Rosin brings nearly two decades of experience in premium consumer health e-Commerce, having previously served as CFO at Wellbeam Consumer Health, TruSkin, NATURELO, Rant, Inc.
  • IM8 is the Company's flagship brand co-founded with David Beckham, reporting approximately $251 million in annualized run-rate revenue within 20 months of launch.